We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,212
Reduced
6,339
Closed
1,910

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Financials 2.35%
3 Healthcare 2.22%
4 Consumer Discretionary 2.21%
5 Communication Services 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFIB
12776
DELISTED
Acutus Medical Inc
AFIB
$84K ﹤0.01%
24,700
-37,072
-60% -$209K
MOTS
12777
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$84K ﹤0.01%
597
+504
+542% +$87.3K
LIBYW
12778
DELISTED
Liberty Resources Acquisition Corp. Warrant
LIBYW
$84K ﹤0.01%
+220,000
New +$84.7K
HCDI
12779
DELISTED
Harbor Custom Development, Inc. Common Stock
HCDI
$84K ﹤0.01%
1,593
+872
+121% +$41.1K
SPPI
12780
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$84K ﹤0.01%
66,100
-39,100
-37% -$69.9K
AGRX
12781
DELISTED
Agile Therapeutics
AGRX
$84K ﹤0.01%
85
+69
+431% +$97.3K
EQOS
12782
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$84K ﹤0.01%
44,815
-4,327
-9% -$16.7K
EVC icon
12783
CALL
Entravision Communication
EVC
$832M
$83K ﹤0.01%
+12,300
New +$93K
PWCM
12784
PUT
PowerCompute Inc
PWCM
$1.18M
$83K ﹤0.01%
+113
New +$96.3K
NGNE icon
12785
Neurogene
NGNE
$723M
$83K ﹤0.01%
864
-254
-23% -$30.9K
OESX icon
12786
Orion Energy Systems
OESX
$79.1M
$83K ﹤0.01%
+2,287
New +$88.4K
TGS icon
12787
PUT
Transportadora de Gas del Sur
TGS
$4.23B
$83K ﹤0.01%
18,800
ZENV
12788
DELISTED
Zenvia
ZENV
$83K ﹤0.01%
+12,261
New +$127K
NBSE
12789
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$83K ﹤0.01%
+1,476
New +$99.1K
NM
12790
CALL
DELISTED
Navios Maritime Holdings Inc.
NM
$83K ﹤0.01%
22,500
+100
+0.4% +$494
SEAC
12791
CALL
DELISTED
Seachange International Inc
SEAC
$83K ﹤0.01%
2,590
-2,485
-49% -$53.5K
AUD
12792
PUT
DELISTED
Audacy, Inc.
AUD
$83K ﹤0.01%
32,400
+4,500
+16% +$13.9K
OSTRW
12793
DELISTED
Oyster Enterprises Acquisition Corp. Warrant
OSTRW
$83K ﹤0.01%
181,423
+100
+0.1% +$54
CRTD
12794
PUT
DELISTED
Creatd Inc. Common Stock
CRTD
$83K ﹤0.01%
39,700
-5,000
-11% -$13.8K
MBII
12795
DELISTED
Marrone Bio Innovations, Inc.
MBII
$83K ﹤0.01%
+115,013
New +$93K
AVEO
12796
PUT
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$83K ﹤0.01%
17,600
-6,800
-28% -$42.2K
BPT
12797
CALL
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$82K ﹤0.01%
20,900
+2,000
+11% +$7.98K
BRW
12798
Saba Capital Income & Opportunities Fund
BRW
$334M
$82K ﹤0.01%
+9,053
New +$82.9K
VLD.WS
12799
DELISTED
Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
VLD.WS
$82K ﹤0.01%
49,351
-77,084
-61% -$166K
ALJJ
12800
DELISTED
ALJ Regional Holdings Inc
ALJJ
$82K ﹤0.01%
+45,110
New +$55.2K

Similar funds

Ken Griffin's Q4 2021 Portfolio in Review

As of Q4 2021, Ken Griffin held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Ken Griffin's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Ken Griffin added most to Amazon in Q4 2021, an estimated $802M increase.
  • Ken Griffin's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Ken Griffin fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Ken Griffin's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Ken Griffin opened 1,894 new positions and closed 1,910 in Q4 2021.
  • Ken Griffin's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.